Matches in Nanopublications for { ?s ?p "DDI between Topotecan and Nilotinib - The p-glycoprotein inhibitor, Nilotinib, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected with IV Topotecan. Concomitant therapy should be avoided."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.